P97-containing Complexes in Proliferation Control and Cancer: Emerging Culprits or Guilt by Association?

Overview

Journal Genes Cancer

Specialty Oncology

Date 2010 Nov 25

PMID 21103003

Citations 20

Authors

Dale S Haines

Affiliations

Soon will be listed here.

Abstract

p97 (also called VCP in metazoans and CDC48 in yeast) is a highly conserved, abundant and essential type II ATPase that functions in numerous ubiquitin signaling dependent processes. p97/Cd48 activities require a growing number of adaptor or accessory proteins that promote interactions with ubiquitinated proteins. p97 has human disease relevance as it is mutated in familial cases of inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia (IBMPFD). There is also increasing evidence suggesting that p97 and/or some of its adaptors play a role in cancer. This review will summarize our existing knowledge of the biochemical, molecular and cellular activities of p97-containing complexes, with an ending focus on their potential role in malignancy.

Citing Articles

UBXN7 cofactor of CRL3 and CRL2 ubiquitin ligase complexes mediates reciprocal regulation of NRF2 and HIF-1α proteins.

Di Gregorio J, Cilenti L, Ambivero C, Andl T, Liao R, Zervos A Biochim Biophys Acta Mol Cell Res. 2021; 1868(4):118963.

PMID: 33444648 PMC: 7882025. DOI: 10.1016/j.bbamcr.2021.118963.

A novel function of AAA-ATPase p97/VCP in the regulation of cell motility.

Khong Z, Lai S, Koh C, Geifman-Shochat S, Li H Oncotarget. 2020; 11(1):74-85.

PMID: 32002125 PMC: 6967774. DOI: 10.18632/oncotarget.27419.

Cooperative subunit dynamics modulate p97 function.

Huang R, Ripstein Z, Rubinstein J, Kay L Proc Natl Acad Sci U S A. 2018; 116(1):158-167.

PMID: 30584095 PMC: 6320498. DOI: 10.1073/pnas.1815495116.

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

Heidelberger J, Voigt A, Borisova M, Petrosino G, Ruf S, Wagner S EMBO Rep. 2018; 19(4).

PMID: 29467282 PMC: 5891417. DOI: 10.15252/embr.201744754.

Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers.

Arumughan A, Roske Y, Barth C, Lleras Forero L, Bravo-Rodriguez K, Redel A Nat Commun. 2016; 7:13047.

PMID: 27762274 PMC: 5080433. DOI: 10.1038/ncomms13047.

References

Chin L, Olzmann J, Li L . Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem Soc Trans. 2010; 38(Pt 1):144-9. PMC: 2846638. DOI: 10.1042/BST0380144. View

Ju J, Miller S, Hanson P, Weihl C . Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J Biol Chem. 2008; 283(44):30289-99. PMC: 2573070. DOI: 10.1074/jbc.M805517200. View

Wang Y, Satoh A, Warren G, Meyer H, Wang Y . VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments. J Cell Biol. 2004; 164(7):973-8. PMC: 2172062. DOI: 10.1083/jcb.200401010. View

Boyault C, Zhang Y, Fritah S, Caron C, Gilquin B, Kwon S . HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev. 2007; 21(17):2172-81. PMC: 1950856. DOI: 10.1101/gad.436407. View

Chen Z, Sun L . Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell. 2009; 33(3):275-86. DOI: 10.1016/j.molcel.2009.01.014. View

Jentsch S, Rumpf S . Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway?. Trends Biochem Sci. 2006; 32(1):6-11. DOI: 10.1016/j.tibs.2006.11.005. View

Pye V, Dreveny I, Briggs L, Sands C, Beuron F, Zhang X . Going through the motions: the ATPase cycle of p97. J Struct Biol. 2006; 156(1):12-28. DOI: 10.1016/j.jsb.2006.03.003. View

Allen M, Buchberger A, Bycroft M . The PUB domain functions as a p97 binding module in human peptide N-glycanase. J Biol Chem. 2006; 281(35):25502-8. DOI: 10.1074/jbc.M601173200. View

Custer S, Neumann M, Lu H, Wright A, Taylor J . Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet. 2010; 19(9):1741-55. DOI: 10.1093/hmg/ddq050. View

10.

Bjorling-Poulsen M, Seitz G, Guerra B, Issinger O . The pro-apoptotic FAS-associated factor 1 is specifically reduced in human gastric carcinomas. Int J Oncol. 2003; 23(4):1015-23. View

11.

Bruderer R, Brasseur C, Meyer H . The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. J Biol Chem. 2004; 279(48):49609-16. DOI: 10.1074/jbc.M408695200. View

12.

Mori-Konya C, Kato N, Maeda R, Yasuda K, Higashimae N, Noguchi M . p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation. Genes Cells. 2009; 14(4):483-97. DOI: 10.1111/j.1365-2443.2009.01286.x. View

13.

Yamamoto S, Tomita Y, Hoshida Y, Nagano H, Dono K, Umeshita K . Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2004; 11(2):165-72. DOI: 10.1245/aso.2004.05.012. View

14.

Li G, Zhao G, Schindelin H, Lennarz W . Tyrosine phosphorylation of ATPase p97 regulates its activity during ERAD. Biochem Biophys Res Commun. 2008; 375(2):247-51. DOI: 10.1016/j.bbrc.2008.08.018. View

15.

Fu X, Ng C, Feng D, Liang C . Cdc48p is required for the cell cycle commitment point at Start via degradation of the G1-CDK inhibitor Far1p. J Cell Biol. 2003; 163(1):21-6. PMC: 2173437. DOI: 10.1083/jcb.200307025. View

16.

Alberts S, Sonntag C, Schafer A, Wolf D . Ubx4 modulates cdc48 activity and influences degradation of misfolded proteins of the endoplasmic reticulum. J Biol Chem. 2009; 284(24):16082-16089. PMC: 2713509. DOI: 10.1074/jbc.M809282200. View

17.

DeLaBarre B, Brunger A . Nucleotide dependent motion and mechanism of action of p97/VCP. J Mol Biol. 2005; 347(2):437-52. DOI: 10.1016/j.jmb.2005.01.060. View

18.

Hirsch C, Gauss R, Horn S, Neuber O, Sommer T . The ubiquitylation machinery of the endoplasmic reticulum. Nature. 2009; 458(7237):453-60. DOI: 10.1038/nature07962. View

19.

Zhao G, Zhou X, Wang L, Li G, Schindelin H, Lennarz W . Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc Natl Acad Sci U S A. 2007; 104(21):8785-90. PMC: 1885580. DOI: 10.1073/pnas.0702966104. View

20.

DeLaBarre B, Christianson J, Kopito R, Brunger A . Central pore residues mediate the p97/VCP activity required for ERAD. Mol Cell. 2006; 22(4):451-62. DOI: 10.1016/j.molcel.2006.03.036. View